Alena Skrahina (Minsk region, Belarus), Raquel Almeida Ferreira Duarte Bessa Melo (Porto, Portugal), Christoph Lange (Borstel, Germany), Chair to be confirmed
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Bae Soohyun (Daegu, Republic of Korea), SooHyun Bae, YooMi Yeo, KyoungWook Jo, TaeSun Shim
|  |
Factors influencing sputum smear conversion delay in tuberculosis
Soumaya Ben Saad (Bizerte, Tunisia), Islam Mejri, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar
|  |
Healing predictors when treating MDR-TB
Houda Snène (Tunis, Tunisia), Houda Snène, Hafaoua Daghfous, Soumaya Ben Saad, Mouna Ben Khelifa, Sameh Belhadj, Leila Slim, Fatma Tritar
| |
Case series of 83 XDR-TB patients in an urban hospital of Gujarat, India; an interim analysis
Kumar Utsav (Varanasi, India), Kumar Utsav, Rajesh N. Solanki
| |
Improvement of the treatment protocol for newly diagnosed pulmonary tuberculosis, depending on the glutathione-S-transferase gene polymorphism
Lilia Todoriko (Chernivtsi, Ukraine), Lilia Todoriko, Igor Semyaniv
| |
Failure predictors when treating MDR-TB
Houda Snène (Tunis, Tunisia), Houda Snène, Hafaoua Daghfous, Soumaya Ben Saad, Mouna Ben Khelifa, Sameh Belhadj, Leila Slim, Fatma Tritar
| |
Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre
Olena Oliveira (Porto, Portugal), Olena Oliveira, Anabela Silva, Ana Antunes, Ricardo Reis, Ana Horta, Raquel Duarte
| |
Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan
Danish Rao (Karachi, Pakistan), Danish Rao, Nisar Rao, Saifullah Baig, Nadeem Ahmed
| |
Short term effects of dendritic cell based immunotherapy in multiple and extensively drug resistant pulmonary tuberculosis in Belarus
Larisa Litskevich (Minsk, Belarus), Litskevich Larysa, Skrahin Alexander, Shpakovskaya Natalia, Hancharou Andrey, I.V. Romanova, Titov Leonid
| |
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Nataliya Zemlyanaya (Tomsk, Russian Federation), Nataliya Zemlyanaya, Irina Gelmanova, Sergey Mishustin, Galina Janova
| |
Active pharmacovigilance for multidrug-resistant tuberculosis patients treated with Linezolid, Belarus – 2014-2015
Alena Skrahina (Minsk region, Belarus), Alena Skrahina, Hennadz Hurevich, Dennis Falzon, Liudmila Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, George Sakvarelidze, Svetlana Setkina
| |
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus
Parvaneh Baghaei Shiva (Tehran, Islamic Republic of Iran), Parvaneh Baghaei, Payam Tabarsi, Mohammad Reza Masjdei
| |
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Karwai Tsang (London, United Kingdom), Karwai Tsang, Ahmed Seedat, Edward Morris, Stella Abiona, Moerida Belton
| |
Could side effects of MDR-TB treatment change the outcome of the disease?
Houda Snène (Tunis, Tunisia), Houda Snène, Hafaoua Daghfous, Soumaya Ben Saad, Mouna Ben Khelifa, Sameh Belhadj, Leila Slim, Fatma Tritar
| |
Side effect profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis
Bhumika Madhav (Navi Mumbai, India), Bhumika Madhav, Aparna Iyer, T.K. Jayalakshmi
| |
The side effects, the outcome and the mortality of anti-tuberculosis treatment in dialyzed patients: A 10-year retrospective analysis
Nayuta Saito (Tokyo, Japan), Nayuta Saito, Yugo Kaneko, Yuri Baba, Hironori Kawamoto, Ikumi Fujisaki, Kai Ryu, Sho Watanabe, Tsugumi Horikiri, Aya Seki, Akira Kinoshita, Hiroshi Takeda, Keisuke Saito, Kazuyoshi Kuwano
| |
Peripheral neuropathy in XDR-TB patients on second line anti-tubercular therapy
Mani Tiwari (Surat, India), Mani Tiwari, Mahendra Patel, Khyati Shamaliya
| |
Confirmation of preclinical data on tioureidoiminomethylpyridinium perchlorate in treatment of MDR-TB
Anna Starshinova (St-Peterburg, Russian Federation), Maria Pavlova, Tatiana Vinogradova, Anna Starshinova, Piotr Yablonskii, Irina Chernokhaeva, Ludmila Archakova, Nadezda Sapozhnikova
| |